JAZZ vs LECO · P/E 1988, rev $2.28B vs P/E 28, rev $2.34B
Jazz Pharmaceuticals PLC (JAZZ) versus Lincoln Electric Holdings Inc (LECO) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Lincoln Electric Holdings Inc (LECO) is a tools & accessories company listed on NASDAQ.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported LECO revenue for 2026-06-30 was $2.34B. Net income was $294.9M. LECO currently screens at market cap $14.77B and trailing P/E 27.8.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. LECO currently screens at market cap $14.77B and trailing P/E 27.8.
Not investment advice. Open the JAZZ and LECO stock pages for the full models.
Not investment advice.